The Irish Times (Free subscription) | yesterday
A DRUG which significantly shrank tumours in 21 men with advanced prostate cancer could provide new hope to patients with this form of the disease.
Medical News Today (Free subscription) | 22/07/2008
A new trial drug called abiraterone has shown a high success rate at treating men with an aggressive, drug resistant, and often fatal form of prostate cancer. 70 to 80 per cent of the men on the trial experienced dramatic reductions in PSA (a protein marker for prostate cancer) and tumour shrinkage, even in tumours that had spread to bone and other tissue.
Medical News Today (Free subscription) | 21/07/2008
A new study published in The Lancet has some promising results for treating Alzheimer's disease (AD) with the drug dimebon. Researchers show that in patients with mild-to-moderate AD, dimebon significantly improves the clinical course of the disease. Unlike any other approved AD therapy, dimebon resulted in increasing benefits over a 12 month period.
Medical News Today (Free subscription) | 21/07/2008
Biocon Limited, India's pioneering biotechnology company, and Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated biotechnology company, announced the launch of ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in India for the treatment of breast cancer after failure of combination therapy for metastatic disease or relapse within six months of adjuvant...
Medical News Today (Free subscription) | 19/07/2008
A new survey reveals that while 82 percent of men with erectile dysfunction (ED) surveyed recognize it as an indicator of other health conditions, such as heart disease and diabetes, nearly 40 percent have never discussed the condition with their doctors.
Kentucky Law Review (Free subscription) | 19/07/2008
Prosecutors pursuing a superseding indictment of more charges in diet drug case in story from Herald Leader: Fen-phen attorneys could face more charges COVINGTON . A federal judge has set an October trial date for two Lexington-area lawyers accused of pocketing millions of dollars that should have gone to their former clients in a diet-drug settlement. But an Oct. 14 start for the second criminal trial...
Bitch News (Free subscription) | 18/07/2008
Alzheimer’s drug trial ‘promise’ , BBC News reports here: A drug once used to treat hayfever “significantly improves” symptoms in patients with mild to moderate Alzheimer’s disease, research suggests.
Kentucky Law Review (Free subscription) | 18/07/2008
New trial date set in fen-phen case HERALD LEADER A federal judge has set Oct. 14 as the start of a retrial for two Lexington lawyers charged in a diet drug settlement case. The Lexington Herald-Leader reported the retrial will likely be pushed back after federal prosecutors said at a court hearing Wednesday that they might seek additional charges against attorneys William Gallion and Shirley Cunningham...
Medical News Today (Free subscription) | 16/07/2008
Using community-based health advocates, delivering information within same-gender groups or adapting dietary and lifestyle advice to fit a particular community's likely diet can help people with type 2 diabetes control their blood sugar levels, certainly for up to six months, following health education. This conclusion was reached by a team of Cochrane Researchers after they considered the data in...
Medical News Today (Free subscription) | 15/07/2008
Six treatments for smoking cessation perform better than placebos - including varenicline (Chantix®), recently approved for use in Canada - states a team of researchers from McGill University and the University of Montreal in an article published in CMAJ.
Medical News Today (Free subscription) | 14/07/2008
Oxygen Biotherapeutics, Inc. (OTCBB:OXBO) is providing an update on the status of the Oxycyte® Phase IIb protocol that has been submitted to the FDA. Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier. "We are in the process of submitting a final piece of information requested by the FDA. After that data has been submitted, we will wait to hear back from them.
soulful sepulcher (Free subscription) | 13/07/2008
GlaxoSmithKline drug trial kills 12 babies in third-world country:an atrocity! Glaxo drug trial kills 12 babies in third -world country. These people have no souls, it's a direct assault on the human life.Period. To use innocent babies to trial a medication is an axis of evil that is an atrocity that should receive no tolerance. As a parent, and mother of 3, this makes me sick. WHY do we
seroxat secrets... (Free subscription) | 13/07/2008
This news coming in today from tradingmarkets.com - maybe it’ll give GSK’s Paul Blackburn some pause for thought as he has such “a passion for children”. 12 Babies die during vaccine trials in Argentina Buenos Aires, Jul 10, 2008 At least 12 babies who were part of a clinical study to test the effectiveness of a vaccine against [...]
Medical News Today (Free subscription) | 10/07/2008
Sciele Pharma, Inc. (NASDAQ:SCRX) announced that it has completed its phase III safety trial utilizing a liquid formulation of glycopyrrolate to treat chronic, moderate-to-severe drooling in pediatric patients. This condition often results from cerebral palsy as well as from other neurological disorders. This trial was designed to evaluate safety parameters for glycopyrrolate over a six-month period....
Medical News Today (Free subscription) | 10/07/2008
Early stage gene therapy clinical trials are recruiting patients from the developing world, providing medically deprived populations access to interventions that show promise but have largely unknown effects in humans. According to commentary by bioethicists at Carnegie Mellon and McGill universities published in this week's issue of The Lancet, the practice may be inconsistent with international ethics...
